Stockreport
*Grifols upgraded to Buy from Hold at Berenberg

Last grifols, sa ads earnings: 5/4 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: grifols.com/en/web/international/investor-relations/home-page
IMPACT SNAPSHOT | EVENT TIME: | GRFS | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GRFS alerts
GRFS alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRFS alerts
High impacting Grifols, SA ADS news events
Weekly update
A roundup of the hottest topics
GRFS
NEWS
NEWS
- Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year[PR Newswire]
- GRIFOLS S A/S (NASDAQ: GRFS) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating.[MarketBeat]
- Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System[PR Newswire]
- GRIFOLS S A/S (NASDAQ: GRFS) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.[MarketBeat]
- Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions[PR Newswire]
- More
GRFS
SEC Filings
SEC Filings
- 2/13/19 - Form SC
- 12/31/18 - Form 6-K
- 12/18/18 - Form 6-K
- GRFS's page on the SEC website
- More